Company Description
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories.
The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services.
Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision.
The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers.
It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand.
Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
| Country | United States |
| Founded | 1931 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 37,500 |
| CEO | Andrew Hider |
Contact Details
Address: One Baxter Parkway Deerfield, Illinois 60015 United States | |
| Phone | 224 948 2000 |
| Website | baxter.com |
Stock Details
| Ticker Symbol | BAX |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000010456 |
| CUSIP Number | 071813109 |
| ISIN Number | US0718131099 |
| Employer ID | 36-0781620 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Scott Kaplan | Senior Vice President of Quality, Regulatory and Patient Safety |
| James Teaff | President of Care and Connectivity Solutions |
| Adriana Guiry | Senior Vice President of Baxter Growth and Performance System |
| Julie Foster | President of Front Line Care |
| Ellen K. Bradford J.D. | Senior Vice President and Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | Filing |
| Mar 23, 2026 | ARS | Filing |
| Mar 23, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 23, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 19, 2026 | 8-K | Current Report |
| Mar 16, 2026 | 8-K | Current Report |
| Mar 13, 2026 | PRE 14A | Other preliminary proxy statements |
| Feb 12, 2026 | 10-K | Annual Report |
| Feb 12, 2026 | 8-K | Current Report |
| Feb 5, 2026 | SCHEDULE 13G | Filing |